6 results
8-K
EX-99.1
VIRX
Viracta Therapeutics Inc
14 May 24
Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer
4:34pm
forward to working with the talented team at Viracta to progress the development of Nana-val and advance the company’s mission to bring innovative
8-K
EX-99.1
VIRX
Viracta Therapeutics Inc
30 Nov 20
Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement
8:02am
. Viracta shares our mission to develop important new targeted treatments for patients living with cancer, and we are enthusiastic about the prospect … of carrying on that mission.”
Ivor Royston, M.D., President and Chief Executive Officer of Viracta added, “The merger and our private financings represent
425
EX-99.1
VIRX
Viracta Therapeutics Inc
30 Nov 20
Business combination disclosure
8:01am
. Viracta shares our mission to develop important new targeted treatments for patients living with cancer, and we are enthusiastic about the prospect … of carrying on that mission.”
Ivor Royston, M.D., President and Chief Executive Officer of Viracta added, “The merger and our private financings represent
8-K
EX-10.1
ezix685nvxr os
19 Oct 11
Sunesis Secures $25 Million Tranched Loan Facility
12:00am
- Prev
- 1
- Next